American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$224M |
| 2 |
BorgWarner
BWA
|
+$155M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$148M |
| 4 |
Booz Allen Hamilton
BAH
|
+$148M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$277M |
| 2 |
Meta Platforms (Facebook)
META
|
+$272M |
| 3 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$254M |
| 4 |
Gilead Sciences
GILD
|
+$217M |
| 5 |
Johnson & Johnson
JNJ
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.58% |
| 2 | Technology | 14.76% |
| 3 | Healthcare | 13.64% |
| 4 | Consumer Discretionary | 12.38% |
| 5 | Industrials | 10.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Corcept Therapeutics
CORT
$11.9B
| $3.51M | ﹤0.01% |
250,550
+2,154
| +0.9% | +$30.1K |
|
927
Phibro Animal Health
PAHC
$1.38B
| $3.5M | ﹤0.01% |
81,699
+2,545
| +3% | +$120K |
|
|
FLOW
928
DELISTED
SPX FLOW, Inc.
FLOW
| $3.47M | ﹤0.01% |
66,746
+5,031
| +8% | +$238K |
|
|
PVG
929
DELISTED
PRETIUM RESOURCES INC.
PVG
| $3.46M | ﹤0.01% |
+454,600
| New | +$3.73M |
|
|
VRS
930
DELISTED
Verso Corporation
VRS
| $3.45M | ﹤0.01% |
+102,561
| New | +$2.68M |
|
931
Caleres
CAL
$461M
| $3.42M | ﹤0.01% |
+95,409
| New | +$3.42M |
|
932
Lear
LEA
$8.16B
| $3.37M | ﹤0.01% |
23,250
-10,710
| -32% | -$1.83M |
|
|
UMPQ
933
DELISTED
Umpqua Holdings Corp
UMPQ
| $3.33M | ﹤0.01% |
+160,241
| New | +$3.5M |
|
934
Abercrombie & Fitch
ANF
$4.84B
| $3.33M | ﹤0.01% |
157,543
+1,071
| +0.7% | +$26K |
|
935
AerCap
AER
$23.5B
| $3.3M | ﹤0.01% |
57,410
+3,331
| +6% | +$188K |
|
936
Innoviva
INVA
$1.5B
| $3.27M | ﹤0.01% |
214,428
-85,783
| -29% | -$1.23M |
|
937
PTC Therapeutics
PTCT
$6.01B
| $3.26M | ﹤0.01% |
69,384
-22,658
| -25% | -$938K |
|
938
iShares TIPS Bond ETF
TIP
$14.7B
| $3.26M | ﹤0.01% |
29,480
| – | – |
|
|
CDK
939
DELISTED
CDK Global, Inc.
CDK
| $3.25M | ﹤0.01% |
+51,888
| New | +$3.29M |
|
|
FLXN
940
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.22M | ﹤0.01% |
172,114
+41,752
| +32% | +$959K |
|
941
Enanta Pharmaceuticals
ENTA
$391M
| $3.21M | ﹤0.01% |
37,606
+5,178
| +16% | +$519K |
|
942
NACCO Industries
NC
$316M
| $3.21M | ﹤0.01% |
98,140
+1,645
| +2% | +$55.8K |
|
943
AppFolio
APPF
$7.22B
| $3.2M | ﹤0.01% |
40,825
+11,558
| +39% | +$874K |
|
|
RESI
944
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $3.19M | ﹤0.01% |
294,030
+2,921
| +1% | +$32.6K |
|
|
ATHN
945
DELISTED
Athenahealth, Inc.
ATHN
| $3.19M | ﹤0.01% |
23,868
+10,431
| +78% | +$1.56M |
|
946
Olin
OLN
$2.17B
| $3.19M | ﹤0.01% |
+124,137
| New | +$3.64M |
|
947
W.P. Carey
WPC
$16.3B
| $3.18M | ﹤0.01% |
50,551
-63,609
| -56% | -$4.09M |
|
948
Lumen
LUMN
$6.6B
| $3.11M | ﹤0.01% |
146,564
+61,268
| +72% | +$1.28M |
|
949
FedEx
FDX
$80.3B
| $3.1M | ﹤0.01% |
12,876
-478,687
| -97% | -$116M |
|
950
Acadia Pharmaceuticals
ACAD
$4.89B
| $3.07M | ﹤0.01% |
147,949
-799
| -0.5% | -$12.6K |
|
Similar funds
American Century Companies's Q3 2018 Portfolio in Review
As of Q3 2018, American Century Companies held 1,415 positions worth $103B, up 3.2% from $99.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
American Century Companies's Q3 2018 filing shows 134 new, 562 increased, 487 reduced and 164 closed positions. Its largest new stake was DocuSign: 1,964,123 shares worth $103M. The largest sale was PepsiCo, an estimated $277M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- American Century Companies's largest Q3 2018 buy was DocuSign: 1,964,123 shares worth $103M.
- American Century Companies added most to Mondelez International in Q3 2018, an estimated $224M increase.
- American Century Companies's biggest Q3 2018 reduction was PepsiCo, cutting an estimated $277M.
- American Century Companies fully exited LKQ Corp in Q3 2018, selling an estimated $99M.
- American Century Companies's ten largest holdings make up 18% of its $103B portfolio in Q3 2018.
- American Century Companies opened 134 new positions and closed 164 in Q3 2018.
- American Century Companies's portfolio value rose 3.2% quarter-over-quarter to $103B.
Based on American Century Companies's 13F filing for Q3 2018, filed 2 Nov 2018.